MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer
Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the FOLFOX regimen versus LV5FU2 in the adjuvant treatment of stage II and III
colon cancer.
Primary objective: Disease Free Survival (DFS) Secondary objective: Overall Survival (OS),
safety (including long term toxicity)